Molecular profiling (MP)-selected therapy for the treatment of patients with advanced pancreaticobiliary cancer (PBC).
Ron Epelbaum
No relevant relationships to disclose
Einat Shacham-Shmueli
No relevant relationships to disclose
Ravit Geva
No relevant relationships to disclose
Ayala Hubert
No relevant relationships to disclose